Venrock Adviser, LLC
NEW YORK, NY · CIK 1615982 · 13F filing filed 2022-02-14
SEC-registered investment adviser since 2014 · limited liability company
- Assets managed$4.5bn
- Staff11 · 11 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds7 (1 hedge) · $4.5bn gross assets
- Form ADV · 2026-04-28SEC adviser record
- Legal entityVENROCK ADVISER, LLC (US)
- Kindhedge funds, private equity
- Others nearbyNew York, NY, Palo Alto, CA
As an employer
- Offices in1 country
- Private fundshedge 1, private equity 6
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| New York, NY (main office)United States | about 11 |
| Palo Alto, CAUnited States |
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
$731.5m
reported value
-6.0% vs Q3 2021
26positions
70.9%in top 10
3 new
6 added
5 reduced
3 sold out
vs Q3 2021
Holdings, Q4 2021
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| INSTIL BIO INC COM | $117.5m16.06% | Unchanged |
| ACLARIS THERAPEUTICS INC ACRS | $66.4m9.07% | Unchanged |
| TRAVERE THERAPEUTICS INC TVTX | $61.9m8.47% | Added +262.6k |
| RELMADA THERAPEUTICS INC RLMD | $51.1m6.99% | Added +882.4k |
| GH RESEARCH PLC GHRS | $47.2m6.45% | Added +379.7k |
| AADI BIOSCIENCE INC WHWK | $36.9m5.05% | Unchanged |
| VIRIDIAN THERAPEUTICS INC VRDN | $36.6m5.01% | Added +1.8m |
| MARINUS PHARMACEUTICALS INC MRNS | $34.2m4.68% | Added +238.3k |
| CELLDEX THERAPEUTICS INC NEW CLDX | $33.4m4.57% | Reduced -233.1k |
| TRICIDA INC TCDA | $33.4m4.57% | Added +3.1m |
| LIANBIO LIANY | $33.1m4.53% | New |
| VISTAGEN THERAPEUTICS INC VTGN | $31.3m4.28% | Unchanged |
| CHINOOK THERAPEUTICS INC ADRO | $20.9m2.86% | New |
| GRAPHITE BIO INC GRPH | $20.0m2.74% | Unchanged |
| NUVALENT INC COM | $15.3m2.09% | Unchanged |
| KINNATE BIOPHARMA INC KNTE | $13.7m1.87% | Reduced -700.0k |
| ATHIRA PHARMA INC COM | $13.0m1.78% | Reduced -196.2k |
| CENTESSA PHARMACEUTICALS PLC SPONSORED ADS | $12.7m1.74% | Unchanged |
| ATYR PHARMA INC ATYR | $11.7m1.60% | Unchanged |
| COGENT BIOSCIENCES INC COGT | $9.3m1.28% | Unchanged |
| AFFIMED N V COM | $7.9m1.08% | New |
| OLEMA PHARMACEUTICALS INC OLMA | $7.6m1.04% | Reduced -719.5k |
| CVRX INC CVRX | $6.5m0.89% | Unchanged |
| AKOYA BIOSCIENCES INC AKYA | $6.1m0.84% | Unchanged |
| ASTRIA THERAPEUTICS INC CATB | $2.9m0.40% | Unchanged |
| CORVUS PHARMACEUTICALS INC CRVS | $603.0k0.08% | Reduced -3.2m |
Sold out since Q3 2021
| Security | Value then |
|---|---|
| ALTIMMUNE INC ALT | $43.0m3.8m shares |
| CULLINAN THERAPEUTICS INC CGEM | $15.9m706.0k shares |
| PHARVARIS N V PHVS | $9.8m552.9k shares |